Clinical Trial Update: The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial investigating whether Thymosin α-1 enhances the efficacy of concurrent chemoradiotherapy followed by immunotherapy consolidation in locally advanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Thymosin α-1 (thymosin alpha-1)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING